Jeff Yass’s Fortress Biotech FBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q3 | $362K | Sell |
169,300
-186,700
| -52% | -$536K | ﹤0.01% | 10531 |
|
|
2026
Q2 | $1.09M | Buy |
356,000
+71,700
| +25% | +$185K | ﹤0.01% | 7984 |
|
|
2026
Q1 | $793K | Buy |
284,300
+61,500
| +28% | +$209K | ﹤0.01% | 8497 |
|
|
2025
Q4 | $815K | Buy |
222,800
+148,500
| +200% | +$423K | ﹤0.01% | 7631 |
|
|
2025
Q3 | $275K | Buy |
74,300
+33,400
| +82% | +$84.4K | ﹤0.01% | 10312 |
|
|
2025
Q2 | $76.1K | Buy |
40,900
+19,600
| +92% | +$33.9K | ﹤0.01% | 11935 |
|
|
2025
Q1 | $33.2K | Buy |
+21,300
| New | +$37.5K | ﹤0.01% | 11982 |
|
|
2024
Q4 | – | Sell |
-12,800
| Closed | -$18.6K | – | 12484 |
|
|
2024
Q3 | $18.6K | Sell |
12,800
-12,200
| -49% | -$23.2K | ﹤0.01% | 11641 |
|
|
2024
Q2 | $42.8K | Buy |
25,000
+15,000
| +150% | +$27.2K | ﹤0.01% | 11473 |
|
|
2024
Q1 | $20K | Sell |
10,000
-6,300
| -39% | -$12.5K | ﹤0.01% | 11818 |
|
|
2023
Q4 | $49.1K | Buy |
+16,300
| New | +$43.1K | ﹤0.01% | 11723 |
|
|
2022
Q2 | – | Sell |
-4,707
| Closed | -$96K | – | 13185 |
|
|
2022
Q1 | $96K | Sell |
4,707
-3,473
| -42% | -$95.1K | ﹤0.01% | 11942 |
|
|
2021
Q4 | $307K | Buy |
8,180
+2,867
| +54% | +$128K | ﹤0.01% | 10449 |
|
|
2021
Q3 | $257K | Buy |
5,313
+1,646
| +45% | +$80.4K | ﹤0.01% | 10952 |
|
|
2021
Q2 | $196K | Buy |
+3,667
| New | +$221K | ﹤0.01% | 11623 |
|
|
2019
Q2 | – | Sell |
-827
| Closed | -$22K | – | 10365 |
|
|
2019
Q1 | $22K | Buy |
+827
| New | +$21.7K | ﹤0.01% | 8581 |
|
|
2016
Q4 | – | Sell |
-3,247
| Closed | -$145K | – | 9724 |
|
|
2016
Q3 | $145K | Buy |
+3,247
| New | +$138K | ﹤0.01% | 7790 |
|
|
2015
Q3 | – | Sell |
-887
| Closed | -$45K | – | 9738 |
|
|
2015
Q2 | $45K | Sell |
887
-946
| -52% | -$48.5K | ﹤0.01% | 9896 |
|
|
2015
Q1 | $106K | Sell |
1,833
-3,667
| -67% | -$153K | ﹤0.01% | 8945 |
|
|
2014
Q4 | $201K | Buy |
5,500
+4,347
| +377% | +$128K | ﹤0.01% | 8807 |
|
|
2014
Q3 | $36K | Sell |
1,153
-1,760
| -60% | -$46.7K | ﹤0.01% | 9273 |
|
|
2014
Q2 | $75K | Sell |
2,913
-87
| -3% | -$2.29K | ﹤0.01% | 9513 |
|
|
2014
Q1 | $89K | Sell |
3,000
-3,027
| -50% | -$118K | ﹤0.01% | 8595 |
|
|
2013
Q4 | $238K | Sell |
6,027
-6,820
| -53% | -$263K | ﹤0.01% | 7978 |
|
|
2013
Q3 | $1.35M | Buy |
12,847
+9,980
| +348% | +$1.22M | ﹤0.01% | 4787 |
|
|
2013
Q2 | $370K | Buy |
+2,867
| New | +$423K | ﹤0.01% | 6483 |
|
Other funds holding FBIO
OM
Jeff Yass's FBIO Position: Q3 2026 in Review
Jeff Yass increased its Fortress Biotech (FBIO) stake by 176% in Q3 2026, buying an estimated $238K and bringing the position to 129,924 shares worth $278K. The position accounts for ﹤0.01% of the portfolio, ranked #11142.
Jeff Yass first reported a position in FBIO in Q2 2013 and has held it in 33 quarters since. The position peaked at $1.32M in Q3 2025. 60 funds tracked by Wall St. Rank hold FBIO as of Q3 2026.
- Jeff Yass held 129,924 shares of Fortress Biotech worth $278K as of Q3 2026.
- Jeff Yass bought 82,922 Fortress Biotech shares in Q3 2026, an estimated $238K.
- Fortress Biotech made up ﹤0.01% of Jeff Yass's portfolio in Q3 2026, its #11142 holding.
- Jeff Yass first reported a position in Fortress Biotech in Q2 2013 and has held it in 33 quarters since.
- Jeff Yass's Fortress Biotech position peaked at $1.32M in Q3 2025.
- 60 funds tracked by Wall St. Rank held Fortress Biotech as of Q3 2026.
Based on Susquehanna International Group's 13F filing for Q3 2026, filed 16 Nov 2026.